| BSE: 533543 | Sector: Health care |
| NSE: BROOKS | ISIN Code: INE650L01011 |
| BSE 00:00 | 24 Feb | 24.75 |
-1.55 (-5.89%) |
OPEN
25.50 |
HIGH
25.50 |
LOW
24.25 |
| NSE 00:00 | 24 Feb | 24.55 |
-1.80 (-6.83%) |
OPEN
26.30 |
HIGH
26.30 |
LOW
24.40 |
| OPEN | 25.50 |
| PREVIOUS CLOSE | 26.30 |
| VOLUME | 19563 |
| 52-Week high | 52.86 |
| 52-Week low | 18.39 |
| P/E | |
| Mkt Cap.(Rs cr) | 61 |
| Buy Price | 24.05 |
| Buy Qty | 1.00 |
| Sell Price | 25.95 |
| Sell Qty | 100.00 |
4.01 pm | 24 Feb 2020 | Business Standard
All that happened in markets today
12.03 pm | 24 Feb 2020 | Business Standard
The stock of India's biggest biotechnology company was trading higher for the third straight day, and has surpassed it's previous high of Rs 321 touch...
11.24 am | 24 Feb 2020 | Business Standard
The company's Ebitda margin expanded by 1,550 basis points to 32.1 per cent in Q3FY20 from 16.6 per cent in Q3FY19
10.04 am | 24 Feb 2020 | Business Standard
Currently, Unit 4 has 15 abbreviated new drug applications (ANDA) approvals pending over the next one year.
9.06 am | 24 Feb 2020 | Business Standard
Here's a look at the top stocks that may remain in focus today
2.19 am | 24 Feb 2020 | Business Standard
Apollo Gleneagles, Kolkata, is a 50:50 joint venture between Apollo Hospitals and the Parkway Group, which is a part of IHH
1.43 am | 22 Feb 2020 | Press Trust of India
It notified the company's management of objectionable conditions at the facility
9.04 pm | 20 Feb 2020 | Business Standard
Dixon Technologies, Havells India, Voltas and Cipla are some of the Indian companies that could face issues over the next few months
12.11 pm | 20 Feb 2020 | Business Standard
The Nifty Midcap index may rally towards 21,000 levels
12.11 pm | 20 Feb 2020 | Business Standard
The Nifty Midcap index may rally towards 21,000 levels
12.11 pm | 20 Feb 2020 | Business Standard
The Nifty Midcap index may rally towards 21,000 levels
10.58 am | 20 Feb 2020 | Business Standard
Glenmark Pharma is continuously going down from Rs 600 levels and is not showing any sign of recovery.
10.58 am | 20 Feb 2020 | Business Standard
Glenmark Pharma is continuously going down from Rs 600 levels and is not showing any sign of recovery.
10.58 am | 20 Feb 2020 | Business Standard
Glenmark Pharma is continuously going down from Rs 600 levels and is not showing any sign of recovery.
10.26 am | 20 Feb 2020 | Business Standard
Trading calls by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Shares and Stock Brokers
10.25 am | 20 Feb 2020 | Business Standard
The United States Food and Drug Administration (USFDA) carried out the inspection of the company's Vizag API manufacturing facility between January 13...
10.13 am | 20 Feb 2020 | Business Standard
Dr Reddy's, Lupin, Sun Pharma and Cadila Healthcare outperformed the local industry growth in recent months, a trend expected to continue
10.13 am | 20 Feb 2020 | Press Trust of India
Pharma major Lupin Ltd on Thursday said it has appointed Sreeji Gopinathan as its Chief Information Officer (CIO). He will lead the IT function for L...
10.12 am | 20 Feb 2020 | Business Standard
Volumes in that market keep growing at 10 per cent a year, but from a value perspective, the growth is single-digit at best, the firm says
10.12 am | 20 Feb 2020 | Business Standard
While pricing pressure in the US generics market remains in low single digits, large product approvals are crucial to boost sales
